September 24, 2019

Upside down

Share on facebook
Share on twitter
Share on linkedin
Share on email

In Short

The negative yield disease is spreading in a way that radically alters portfolio considerations. We argue that the economic pain threshold justifying a switch away from risky assets is higher than it used to be. Investors have been punished for rushing away from equities into bonds.
Upside down
Share on facebook
Share on twitter
Share on linkedin
Share on email

Highlights:

  • The negative yield disease is spreading in a way that radically alters portfolio considerations. We argue that the economic pain threshold justifying a switch away from risky assets is higher than it used to be. Investors have been punished for rushing away from equities into bonds.
  • The million dollar question is whether the global economy, now on a dangerous slope, will fall into recession. This is not our core scenario, but policy support – not just monetary – is required. We assume none of the three major risks (Brexit, US/China trade war, Middle East tensions) will materialize in the worst way.
  • In the upside-down world of negative yields, IG Credit is a new safe haven – symbolized by the outright and relative low IG yield volatility. Equities remain cheap relative to bonds, and the Fed will remain supportive (we do not believe in the FOMC’s hawkish dot plot).
  • We reduce our long duration following sharp EUR 10-30y flattening. Credit duration offers more value. We stay underweight short-dated EUR Govies. With the USD looking toppish, EM equities and bonds offer selective opportunities.

Download the full publication below

Also interesting

us-federal-reserve-washington-spring_web
January 27, 2021
Market Commentary

The Fed tells not to worry about inflation, as it has to finish its job

Macro-view-trading-terminal-chart-digits
January 25, 2021
Market Commentary

US Q4 earnings season starts better than Q3 one. Expect good earnings momentum to linger, supporting positive total returns this year.

size 3
January 22, 2021
Market Commentary

COVID-19 FACTS & FIGURES